Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Q3 2023 Earnings Call Transcript November 8, 2023
Lexicon Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0.21, expectations were $-0.22.
Operator: Good day and welcome to the Lexicon Pharmaceuticals’ Third Quarter 2023 Financial Results Conference Call. Today all participants will be in a listen-only mode. [Operator Instructions] After today’s presentation, there will be an opportunity to ask questions. [Operator Instructions]...
